AS

Alfiya Shaikh Mohammed Umais

Active Director Additional Director DIN 11127832
DIN 11127832 First appointment May 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Alfiya Shaikh Mohammed Umais

Data last updated:

Alfiya Shaikh Mohammed Umais is an Additional Director at Indoglobe Pharma Private Limited (since 2025). The company operates in Paper.

DIN 11127832
Primary Designation Additional Director
Industry Paper
First Appointment 28 May 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indoglobe Pharma Private Limited U21001MH2024PTC424150
Additional Director28 May 20252024Active

Board colleagues of Alfiya Shaikh Mohammed Umais

Directorship timeline

Open interactive timeline →
Indoglobe Pharma Private Limited
Premium access

Shareholding and investment profile for Alfiya Shaikh Mohammed Umais

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alfiya Shaikh Mohammed Umais

Alfiya Shaikh Mohammed Umais currently holds 1 directorship: Indoglobe Pharma Private Limited (Additional Director, since 28 May 2025).

Alfiya Shaikh Mohammed Umais was first appointed on 28 May 2025 as Additional Director at Indoglobe Pharma Private Limited.

The current boards of Alfiya Shaikh Mohammed Umais's companies include Farheen Sadik Pathan (Indoglobe Pharma Private Limited), Shoheb Babulal Shaikh (Indoglobe Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available